Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BENDAMUSTINE vs BENRALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BENDAMUSTINE vs BENRALIZUMAB: Safety Overview

Metric BENDAMUSTINE BENRALIZUMAB
Total FAERS Reports 19,667 15,738
Deaths Reported 3,988 1,618
Death Rate 20.3% 10.3%
Hospitalizations 7,576 3,707
Average Patient Age 65.5 yrs 59.1 yrs
% Female Patients 40.1% 69.4%
FDA Approval Date Apr 28, 2023 N/A
Manufacturer Azurity Pharmaceuticals, Inc. AstraZeneca Pharmaceuticals LP
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription